Update results of FEC followed by docetaxel neoadjuvant trials for primary breast cancer.
Ohnoa S, Toi M, Kuroi K, Nakamura S, Iwata H, Kusama M, Masuda N, Yamazaki K, Hisamatsu K, Sato Y, Takatsuka Y, Shin E, Kaise H, Kurozumi M, Tsuda H, Akiyama F.
Ohnoa S, et al. Among authors: masuda n.
Biomed Pharmacother. 2005 Oct;59 Suppl 2:S323-4. doi: 10.1016/s0753-3322(05)80063-0.
Biomed Pharmacother. 2005.
PMID: 16507401